Nicotine, a non-selective α7 nicotinic acetylcholine receptor (α7nAChR) agonist, ameliorates DSS-induced colitis in vivo and in vitro by activating the AMPK-mTOR-p70S6K signaling pathway. The gene discussed is MTOR; the disease is colitis.